Home

Recent Articles from Business Wire

Cleverbridge Announces Leadership Transition
Cleverbridge, a leading provider of ecommerce and billing solutions for global software companies, today announced the appointment of Richard Stevenson as Chief Executive Officer, effective April 1, 2025. He succeeds Wendi Sturgis, who will transition into a board advisory role.
By Cleverbridge · Via Business Wire · March 31, 2025
NFC Forum Publishes Candidate Specification For Sustainability Data Management
NFC Forum, the global standards body for Near Field Communication (NFC) technology, has published its NFC Digital Product Passport (NDPP) Candidate Specification. The new proposal enables NFC Forum tags already in use for other applications to also store sustainability data. The ability for this information to coexist with existing NFC applications lays the foundation for an accessible, interoperable sustainability data management ecosystem that can vastly accelerate the advancement of the circular economy.
By NFC Forum · Via Business Wire · March 31, 2025
Advantage Distribution Holdings Completes Acquisition of CTC Supply
Advantage Distribution Holdings (“ADH”), an HVAC distribution platform backed by Tigertail Capital Partners (“TCP”), is pleased to announce its acquisition of CTC Supply (“CTC” or the “Company”). Founded in 2000, CTC is a leading distributor of HVAC equipment, parts, and supplies used primarily in residential single-family and multi-family end-markets.
By Tigertail Capital Partners · Via Business Wire · March 31, 2025
Gartner Forecasts Worldwide GenAI Spending to Reach $644 Billion in 2025
Worldwide generative AI (GenAI) spending is expected to total $644 billion in 2025, an increase of 76.4% from 2024, according to a forecast by Gartner, Inc.
By Gartner, Inc. · Via Business Wire · March 31, 2025
Ideagen shines in G2 Spring 2025 Reports with 82 badges and 31 top rankings
Global software company, Ideagen, is celebrating success in the G2 Spring 2025 Reports, earning 82 prestigious badges and 31 number one rankings this season – all thanks to the valued feedback from customers.
By Ideagen · Via Business Wire · March 31, 2025
Sphere Bio launches Cyto-Cellect Human IgG Kappa and Viability Assay Kit for efficient single-cell selection
Sphere Bio, a leading provider of innovative picodroplet-based microfluidics solutions for functional single-cell analysis and isolation, today announced the launch of the Cyto-Cellect® Human IgG Kappa and Viability Assay Kit, the first multiplexed assay developed specifically for the Company’s new Cyto-Mine® Chroma platform.1
By Sphere Bio · Via Business Wire · March 31, 2025
Convatec Announces Exclusive Collaboration With Largest Wound, Ostomy and Continence Professional Nursing Organisation
Convatec, a leading medical products and technologies company focused on solutions for the management of chronic conditions, is excited to announce its global collaboration with the Wound, Ostomy, and Continence Nurses Society™ (WOCN®), the largest and most recognised professional nursing community dedicated to advancing the practice and delivery of expert healthcare to individuals with wound, ostomy, and continence care needs.
By Convatec · Via Business Wire · March 31, 2025
Village Island Enhances its AI100 with intoPIX’s JPEG XS Technology for Advanced Real-Time Analysis
intoPIX announces the successful addition of its JPEG XS technology to the new Village Island AI100 system. The AI100 is a professional real-time test and measurement analyzer that offers comprehensive ST 2110 support.
By intoPIX · Via Business Wire · March 31, 2025
Strategy Playbook of the World's Top 7 Aerospace & Defense Companies: Airbus, BAE Systems, Boeing, General Dynamics, Lockheed Martin, Northrop Grumman, RTX - ResearchAndMarkets.com
The "Strategy Playbooks - 2025 - World's Top 7 Aerospace & Defense Companies - Airbus, BAE Systems, Boeing, General Dynamics, Lockheed Martin, Northrop Grumman, RTX - Strategy Focus, Key Strategies & Plans, SWOT, Trends & Growth Opportunities, Business and Market Outlook" company profile has been added to ResearchAndMarkets.com's offering.
By Research and Markets · Via Business Wire · March 31, 2025
Enigma Biomedical USA, Inc. Announces a Collaboration to Apply Novel 4R PET Imaging Biomarkers to CTE Research
Enigma Biomedical USA, Inc. (EB USA) today announced that it is starting a collaboration with the Boston University Chronic Traumatic Encephalopathy (CTE) Center and the Concussion Legacy Foundation. This collaboration will focus on demonstrating the value of 4R Tau PET imaging biomarkers in advancing our understanding of CTE.
By Enigma Biomedical USA, Inc. · Via Business Wire · March 31, 2025
HighByte Announces Support for Amazon S3 Tables
HighByte®, an industrial software company, is working with Amazon Web Services, Inc. (AWS), to improve the accessibility and usage of operational technology (OT) data in the cloud. The new native integration available in HighByte Intelligence Hub makes it easier for global manufacturers to build an open, transactional data lake for their industrial data and help to optimize the management, performance, and storage of tabular data for analytics workloads with Amazon S3 Tables.
By HighByte · Via Business Wire · March 31, 2025
Nidec Precision Executes Agreement to Transfer Its Shares in Nidec Precision Yamada
NIDEC CORPORATION (TOKYO: 6594; OTC US: NJDCY) and NIDEC PRECISION CORPORATION (“NIDEC PRECISION” or the “Company”) announced today that, at a meeting of the Board of Directors held on March 18, 2025, they resolved to transfer NIDEC PRECISION’s shares (approximately 68.4%) in NIDEC PRECISION YAMADA CORPORATION (the “Target Company”), a subsidiary of the Company and joint venture with APIC YAMADA CORPORATION (“APIC YAMADA”), to APIC YAMADA (the “Share Transfer”), and executed a share transfer agreement on March 31, 2025, completing the Share Transfer on the same day.
By Nidec Corporation · Via Business Wire · March 31, 2025
Mitsubishi Electric Announces Director Candidates
Mitsubishi Electric Corporation (TOKYO: 6503) announced today that the candidates for Directors, who will be proposed for election at the Ordinary General Meeting of Shareholders scheduled in June 2025, were elected at the company’s Nomination Committee meeting held earlier today.
GE HealthCare Completes Acquisition of Nihon Medi-Physics (NMP), a Leading Radiopharmaceutical Company in Japan
GE HealthCare Technologies Inc. (GE HealthCare or the Company) (Nasdaq: GEHC) has completed its acquisition of the remaining 50% stake in Nihon Medi-Physics Co., Ltd (NMP), from Sumitomo Chemical, giving it full ownership. As part of GE HealthCare, NMP can further build on its expertise in developing and manufacturing proprietary and in-licensed radiopharmaceuticals used in single photon emission computed tomography (SPECT) and positron emission tomography (PET) molecular imaging procedures to detect and diagnose disease.
Allianz Trade Announces Changes in Leadership Teams
Allianz Trade, the world leader in trade credit insurance, announces changes in its leadership teams. Benoît des Cressonnières, Global Head of Reinsurance of Allianz Trade and CEO of Euler Hermes Reinsurance AG, will retire on September 30th, 2025. Philippe Dessèvre, currently CFO of Allianz Trade in DACH, will succeed him as of October 1st, 2025. This appointment is subject to the standard regulatory approval requirements.
By Allianz Trade · Via Business Wire · March 31, 2025
New Accenture Siemens Business Group to Reinvent Engineering and Manufacturing for Clients
Siemens and Accenture (NYSE: ACN) are significantly advancing their long-standing alliance partnership to help clients reinvent and transform engineering and manufacturing.
By Accenture · Via Business Wire · March 31, 2025
Sensorion Announces Webconference, in French, for its Retail Shareholders on April 7, 2025
Regulatory News:
By Sensorion · Via Business Wire · March 31, 2025
BW LPG Signs MOA to Sell Two VLGCs to BW LPG India
BW LPG Limited (“BW LPG”, OSE ticker code: “BWLPG.OL”, NYSE ticker code “BWLP”) has signed a Memorandum of Agreement (MOA) with BW LPG India to sell two vessels acquired in the recent Avance Gas transaction – BW Pampero and BW Chinook to BW LPG India (the ‘transaction’) at a price of approximately USD 75 million per vessel to ensure further expansion and fleet renewal in the Indian market. The delivery of the two vessels is expected in Q3 2025.
By BW LPG Limited · Via Business Wire · March 31, 2025
Poxel Announces Grant of New Patent in Japan for the Use of Imeglimin in Type-2 Diabetic Patients with Renal Impairment
Regulatory News:
By Poxel SA · Via Business Wire · March 31, 2025
Novotech Welcomes New Investment From GIC, Temasek, and Existing Investor TPG to Accelerate Global Growth
Novotech, a globally recognized full-service biotech specialist clinical research organization (CRO), announced today that affiliates of GIC and Temasek have signed binding agreements to acquire a significant stake in the company, with the additional capital earmarked to accelerate its global growth. Existing investor TPG will also reinvest through its TPG Asia fund.
By Novotech · Via Business Wire · March 30, 2025
Faraday Future Delivers First FF 91 2.0 Futurist Alliance in the East Coast Market to Univest Securities
Faraday Future Intelligent Electric Inc. (Nasdaq: FFAI) (“FF”, “Faraday Future”, or the “Company”), a California-based global shared intelligent electric mobility ecosystem company, today announced that it delivered an FF 91 2.0 Futurist Alliance to Univest Securities, LLC, a boutique investment firm based in New York City. The delivery, which took place near Midtown Manhattan, is FF’s first delivery in New York State and signifies a historic moment for the Company. FF went public on Nasdaq in 2021 and at the time studied the feasibility of expanding to this region. That possibility has now been realized, laying the foundation for not only additional sales of the FF 91 2.0 but also for potential future FX models.
Yen Press Titles Now Available on MangaPlaza
Yen Press and NTT Solmare Corp. have announced that Yen Press’s Manga titles are now available on MangaPlaza, one of the U.S.’s largest digital manga content libraries. To celebrate this momentous occasion, MangaPlaza is launching a point reward promotion for all Yen Press’s titles including manga, v-scroll comics and light novels.
By NTT Solmare Corporation · Via Business Wire · March 30, 2025
VeriSilicon Introduces AcuityPercept: an AI-Powered Automatic ISP Tuning System
VeriSilicon (688521.SH) today announced AcuityPercept, its AI-based automatic Image Signal Processing (ISP) tuning system, designed to intelligently optimize image processing parameters for enhanced object recognition. AcuityPercept improves the accuracy and efficiency of AI perception systems by dynamically optimizing ISP parameters through automated tuning processes. It is widely applicable to AI-powered vision applications across various industries, including autonomous driving, robotic vision, and AIoT.
By VeriSilicon · Via Business Wire · March 30, 2025
I Squared Capital Announces $300 Million Investment from Rest into its Credit Strategy
I Squared Capital, a leading global infrastructure investment manager, today announced a USD $300 million commitment from Rest, one of Australia’s largest profit-to-member superannuation funds.
By I Squared Capital · Via Business Wire · March 30, 2025
EU INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that enCore Energy Corp. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against enCore Energy Corp. (“enCore” or “the Company”) (NASDAQ: EU) and certain of its officers.
TFII INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that TFI International Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against TFI International Inc. (“TFI” or “the Company”) (NYSE: TFII) and certain of its officers.
UCTT INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Ultra Clean Holdings, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Ultra Clean Holdings, Inc. (“Ultra Clean” or “the Company”) (NASDAQ: UCTT) and certain of its officers.
Undeclared Allergens in Trader Joe’s Hot Honey Mustard Dressing With Use by Date of 05/27/2025 Issued by Fresh Creative Foods
Fresh Creative Foods is voluntarily recalling a single item with a specific use by date, produced at a regional facility and distributed to limited Trader Joe’s locations. The product is Trader Joe’s Hot Honey Mustard Dressing, with a Use By Date of 05/27/2025 due to labeling error. The incorrect label does not include allergen callouts for peanuts, soy, sesame, or wheat.
By Fresh Creative Foods · Via Business Wire · March 30, 2025
Clinical Data Presented at ACC 2025 Shows Sensydia CPS™ Provides Accurate Assessment of Mean Pulmonary Artery Pressure Non-Invasively
Sensydia, a clinical-stage non-invasive cardiac assessment company, announced today that University of Minnesota investigators presented positive clinical findings from a recent study evaluating the company’s AI-powered, non-invasive Cardiac Performance System (CPS™) in a poster presentation at the American College of Cardiology (ACC) 2025 Annual Scientific Session & Expo at the McCormick Place Convention Center in Chicago, IL.
By Sensydia · Via Business Wire · March 30, 2025
Rain Tree Photonics Unveils 200G/Lane PIC Product Family and Advancements in 400G/Lane IMDD for Future AI Connectivity
Rain Tree Photonics (RTP), a leading innovator in silicon photonics, is proud to announce the availability of its 200G/lane Photonic Integrated Circuit (PIC) product family, designed to meet the increasing bandwidth and efficiency demands of AI clusters and hyperscale data centers.
By Rain Tree Photonics · Via Business Wire · March 30, 2025
Source Photonics Showcases Industry’s First-Ever 200G/Lane Multi-Channel Monolithic InP PIC to Power 1.6T IMDD Transceiver Technology
Source Photonics Inc., a leading global provider of innovative and reliable technology solutions for communications and data connectivity for use in hyperscale and AI datacenters, will be showcasing the industry’s first-ever 200G per lane multi-channel monolithic InP photonic integrated circuit (PIC) single mode intensity-modulation direct-detection (IMDD) technology to support 1.6Tbps and future 3.2Tbps transceivers for intra-data center and campus data center interconnection applications.
By Source Photonics Inc. · Via Business Wire · March 30, 2025
SOLARIS SHAREHOLDER ALERT by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Reminds Investors With Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Solaris Energy Infrastructure, Inc. - SEI
Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until May 27, 2025 to file lead plaintiff applications in a securities class action lawsuit against Solaris Energy Infrastructure, Inc. (“Solaris” or the “Company”) (NYSE: SEI), if they purchased the Company’s securities between July 9, 2024 and March 17, 2025, inclusive (the “Class Period”). This action is pending in the United States District Court for the Southern District of Texas.
By Kahn Swick & Foti, LLC · Via Business Wire · March 29, 2025
Alnylam Presents New Data from the HELIOS-B Phase 3 Study of Vutrisiran in Patients with ATTR Amyloidosis with Cardiomyopathy (ATTR-CM) at the American College of Cardiology’s Annual Scientific Session 2025
Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today announced moderated poster presentations of new data from the landmark HELIOS-B Phase 3 clinical trial, which evaluated vutrisiran for the treatment of ATTR amyloidosis with cardiomyopathy (ATTR-CM) in a population representative of today’s patients. Data were presented at the American College of Cardiology’s Annual Scientific Session (ACC.25) held in Chicago, Illinois. These data build upon the body of clinical evidence which supported the recent U.S. Food and Drug Administration (FDA) approval of AMVUTTRA® (vutrisiran) for the treatment of the cardiomyopathy of wild-type or hereditary transthyretin-mediated amyloidosis in adults to reduce cardiovascular mortality, cardiovascular hospitalizations and urgent heart failure visits. AMVUTTRA is an RNAi therapeutic that works upstream to deliver rapid knockdown of transthyretin, addressing the disease at its source, with four subcutaneous doses per year.
By Alnylam Pharmaceuticals, Inc. · Via Business Wire · March 29, 2025
Tempus Exhibits 4 Abstracts at the 2025 American College of Cardiology Annual Meeting
Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today announced the company is scheduled to exhibit 4 abstracts at the American College of Cardiology (ACC) Annual Meeting, which convenes from March 29-31 in Chicago, Illinois. This is the first year that Tempus is presenting research, all of which highlights the application of AI to support clinicians in delivering personalized care.
By Tempus AI, Inc. · Via Business Wire · March 29, 2025
ConcertAI’s TeraRecon and 3DR Labs Announce Expanded Partnership to Transform the Delivery of AI-Enabled Image Post Processing Clinical Services for US Healthcare Providers
ConcertAI's TeraRecon, a leader in integrating advanced imaging workflows with clinical AI, has announced an expanded partnership with 3DR® Labs, a leading provider of 3D medical image post-processing and clinically integrated AI services in the United States. This collaboration aims to enhance clinical service delivery for advanced imaging by expanding the range of domain-specific workflows and clinical AI technologies. As a result, it will benefit numerous hospitals across the country.
By ConcertAI · Via Business Wire · March 29, 2025
SEI CLASS ACTION NOTICE: Glancy Prongay & Murray LLP Files Securities Fraud Lawsuit On Behalf Of Solaris Energy Infrastructure, Inc. Investors
Glancy Prongay & Murray LLP (“GPM”), announces that it has filed a class action lawsuit in the United States District Court for the Southern District of Texas, captioned Pirello v. Solaris Energy Infrastructure, Inc., et al., Case No. 25-cv-01455, on behalf of persons and entities that purchased or otherwise acquired Solaris Energy Infrastructure, Inc. (“Solaris” or the “Company”) (NYSE: SEI) securities between July 9, 2024 and March 17, 2025, inclusive (the “Class Period”). Plaintiff pursues claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 (the “Exchange Act”).
By Glancy Prongay & Murray LLP · Via Business Wire · March 28, 2025
Sunnova Adopts Tax Asset Preservation Plan Designed to Protect the Availability of its Net Operating Losses
Sunnova Energy International Inc. (“Sunnova”) (NYSE: NOVA) announced today that its Board of Directors adopted a shareholder rights plan designed to protect long-term shareholder value by preserving the availability of Sunnova’s net operating loss carryforwards (“NOLs”) and other tax attributes under the Internal Revenue Code (“Tax Asset Preservation Plan”).
Xerox Corporation Announces the Successful Pricing of $800 million Senior Secured Notes
Xerox Corporation today announced that it has successfully priced an offering of (i) $400,000,000 in aggregate principal amount of 10.250% Senior Secured First Lien Notes due 2030 (the “First Lien Notes”) to be issued by Xerox Corporation and guaranteed by Xerox Holdings Corporation (“Xerox” and, together with Xerox Corporation, the “Company”) and certain of Xerox’s domestic and foreign subsidiaries and (ii) $400,000,000 in aggregate principal amount of 13.500% Senior Secured Second Lien Notes due 2031 (the “Second Lien Notes” and, together with the First Lien Notes, the “Notes”) to be issued by Xerox Issuer Corporation (the “Escrow Issuer”), a wholly-owned subsidiary of Xerox Corporation.
By Xerox Corporation · Via Business Wire · March 28, 2025
Generation Mining Announces Filing of Marathon Copper-Palladium Project Technical Report
Generation Mining Limited (TSX: GENM; OTCQB: GENMF) (“Gen Mining” or the “Company”) has filed a National Instrument 43-101 Technical Report entitled “Marathon Copper-Palladium Project - Feasibility Study Report Update", dated March 28, 2025, with an effective date of November 1, 2024, the results of which were announced by the Company in a news release issued on March 27, 2025.
By Generation Mining Limited · Via Business Wire · March 28, 2025
GITLAB INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of GitLab Inc. - GTLB
Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF has commenced an investigation into GitLab Inc. (“the Company”) (NasdaqGS: GTLB).
By Kahn Swick & Foti, LLC · Via Business Wire · March 28, 2025
With MCP, AI Agents Now Have Power. SGNL Makes Sure They Use It Responsibly.
A new wave of AI-powered automation is hitting the enterprise. Agents powered by large language models (LLMs) are now capable of performing real tasks across internal systems — from updating records to analyzing data and taking action — all triggered by a simple prompt. But with that power comes risk: without proper controls, these agents can access far more than they should.
By SGNL · Via Business Wire · March 28, 2025
Hesai Group (NASDAQ: HSAI) Securities Fraud Investigation; Investors Urged to Contact Award-Winning Firm, Gibbs Mura
Gibbs Mura encourages Hesai Group shareholders to contact our team about recovering their losses through a potential Hesai Group (NASDAQ: HSAI) Securities Class Action Lawsuit. Shares of Hesai Group fell over 10% in intraday trading on Tuesday, March 18, 2025, after Blue Orca Capital published a report alleging that the company is a “Chinese scam actively lying to investors, the Department of Defense, and a United States federal court” and that it significantly overstated its revenue from 2019-2023.
By Gibbs Mura · Via Business Wire · March 28, 2025
FCPT Announces Sale-Leaseback of a Portfolio of Six Whataburger Properties from MWB Restaurants for $16.8 Million
Four Corners Property Trust (NYSE:FCPT), a real estate investment trust primarily engaged in the ownership and acquisition of high-quality, net-leased restaurant and retail properties (“FCPT” or the “Company”), is pleased to announce the acquisition of six Whataburger properties for $16.8 million from MWB Restaurants via sale-leaseback. The properties are newly constructed and located in strong retail corridors in Alabama and franchisee-operated under long term, triple net leases with approximately 20 years of term remaining. The transaction was priced at a 6.8% cap rate on rent as of the closing date and exclusive of transaction costs.
By Four Corners Property Trust · Via Business Wire · March 28, 2025
VIQ Solutions Delivers $6.0M Adjusted EBITDA Year-Over-Year Improvement in FY 2024, fueled by AI-Driven Automation, Cost Optimization, and Strategic Customer Contract Renewals
VIQ Solutions Inc. (“VIQ” or the “Company”) (TSX: VQS), a global leader in secure, AI-driven voice and video capture technology and transcription services, today announced its unaudited financial results for the fourth quarter and fiscal year ended December 31, 2024. All figures are in U.S. dollars and prepared in accordance with International Financial Reporting Standards (IFRS).
By VIQ Solutions Inc. · Via Business Wire · March 28, 2025
INTEGRAL AD 72 HOUR DEADLINE ALERT: Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors With Losses in Excess of $100,000 of Deadline in Class Action Lawsuit Against Integral Ad Science Holding Corp. - IAS
Kahn Swick & Foti, LLC (“KSF”) and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until March 31, 2025 to file lead plaintiff applications in a securities class action lawsuit against Integral Ad Science Holding Corp. (the “Company”) (NasdaqGS: IAS), if they purchased the Company’s shares between March 2, 2023 and February 27, 2024, inclusive (the “Class Period”). This action is pending in the United States District Court for the Southern District of New York.
By Kahn Swick & Foti, LLC · Via Business Wire · March 28, 2025
CAREDX INVESTIGATION CONTINUED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of CareDx, Inc. - CDNA
Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF continues its investigation into CareDx, Inc. (NasdaqGM: CDNA).
By Kahn Swick & Foti, LLC · Via Business Wire · March 28, 2025
August Schools Launches First AI Agent for K-12
August Schools, a SaaS platform for student wellbeing management, announced the launch of August Intelligence, the first AI agent designed to help schools access critical insights, streamline administrative tasks, and enhance student support.
By August Schools · Via Business Wire · March 28, 2025
GERN Investors Have Opportunity to Lead Geron Corporation Securities Fraud Lawsuit with the Schall Law Firm
The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Geron Corporation (“Geron” or “the Company”) (NASDAQ: GERN) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
By The Schall Law Firm · Via Business Wire · March 28, 2025
iolite Confirms Special Meeting of Dynacor Group Inc. – Meeting to Proceed Despite Attempts by Dynacor to Block It in Court
iolite Capital Management AG, a Switzerland-based investment manager (“iolite”), as representative of iolite Partners Ltd. called a special meeting of the holders ("Shareholders") of common shares of Dynacor Group Inc. (the “Company”) to elect Robert Leitz to the board of directors of the Company which is scheduled to take place on April 16, 2025 (the "Meeting").
By iolite Capital Management AG · Via Business Wire · March 28, 2025
Diopsys, Inc. Announces Settlement with the Department of Justice
Diopsys, Inc. has settled all claims with the Department of Justice related to its Nova ERG device marketing activities from the period of 2015-2021. The settlement provides for a series of guaranteed payments totaling $1,225,000 and contingent payments up to a maximum of $13,025,000 to be made over a period of 6 years.
By Diopsys, Inc. · Via Business Wire · March 28, 2025
Innovative Industrial Properties Reports Defaults by Tenants
Innovative Industrial Properties, Inc. (IIP) (NYSE: IIPR), a leading real estate investment trust specializing in the regulated cannabis industry, today announced a significant tenant replacement and renewal initiative aimed at enhancing the performance of its real estate portfolio and driving long-term value for shareholders. This initiative focuses on strengthening tenant credit profiles and optimizing occupancy of the Company’s properties to align with evolving market demands.
The Fairholme Focused Income Fund Announces Dividend
On March 28, 2025, the Fairholme Focused Income Fund (“FOCIX” or the “Fund”) distributed an Ordinary Income dividend of $0.06955 per share to shareholders of record as of March 27, 2025. The Fund’s Net Asset Value (“NAV”) was reduced by the amount of the distribution.
By Fairholme Funds, Inc. · Via Business Wire · March 28, 2025
Rosen Law Firm Urges Actinium Pharmaceuticals, Inc. (NYSE American: ATNM) Stockholders with Losses in Excess of $100K to Contact the Firm for Information About Their Rights
Rosen Law Firm, a global investor rights law firm, announces that a shareholder filed a class action on behalf of purchasers of securities of Actinium Pharmaceuticals, Inc. (NYSE American: ATNM) between October 31, 2022, and August 2, 2024. Actinium describes itself as a “late-stage biopharmaceutical company that develops targeted radiotherapies.”
By The Rosen Law Firm, P.A. · Via Business Wire · March 28, 2025
BRW Announces Notification of Sources of Distributions
Saba Capital Income & Opportunities Fund (NYSE: BRW) (the “Fund”), a registered closed-end management investment company listed on the New York Stock Exchange, is notifying shareholders, prospective shareholders, and third parties of the sources of distributions pursuant to Section 19(a) of the Investment Company Act of 1940 (the “Investment Company Act”).
SABA Announces Notification of Sources of Distributions
Saba Capital Income & Opportunities Fund II (NYSE: SABA) (the “Fund”), a registered closed-end management investment company listed on the New York Stock Exchange, is notifying shareholders, prospective shareholders, and third parties of the sources of distributions pursuant to Section 19(a) of the Investment Company Act of 1940 (the “Investment Company Act”).
1st Summit Bancorp of Johnstown, Inc. Announces Resignation of President and Chief Executive Officer and Appointment of New President and Chief Executive Officer
1st Summit Bancorp of Johnstown, Inc. (OTC Pink: FSMK), the parent company for 1st Summit Bank (the “Bank”), announced today that Eric Renner has submitted his voluntary resignation due to personal reasons as President and Chief Executive Officer and Director of the Company and the Bank, effective March 28, 2025. Mr. Renner has served in these positions at the Bank since June 2020 and of the Company since January 2023.
Retractable Technologies, Inc. Reports Results for 2024
Retractable Technologies, Inc. (NYSE American: RVP) reports the following information relating to the year ended December 31, 2024. Further details concerning the results of operations as well as other matters are available in Retractable’s Form 10-K filed on March 28, 2025 with the U.S. Securities and Exchange Commission.
By Retractable Technologies, Inc. · Via Business Wire · March 28, 2025
Securities Fraud Investigation Into Actinium Pharmaceuticals, Inc. (ATNM) Announced – Investors Who Lost Money Urged to Contact The Law Offices of Frank R. Cruz
The Law Offices of Frank R. Cruz announces an investigation of Actinium Pharmaceuticals, Inc. (“Actinium” or the “Company”) (NYSE American: ATNM) on behalf of investors concerning the Company’s possible violations of federal securities laws.
By Law Offices of Frank R. Cruz · Via Business Wire · March 28, 2025
Retractable Technologies, Inc. Declares Dividends to Series II and III Class B Preferred Stock Shareholders
Retractable Technologies, Inc. (“Retractable”) (NYSE American: RVP) announced today that its Board of Directors has declared dividends to holders of its Series II Class B and Series III Class B Convertible Preferred Stock in the amounts of $39,050.00 and $18,561.25, respectively. Dividends have accrued at $1.00 per share per annum. The dividends cover the period beginning January 1, 2025 through March 31, 2025. The dividends will be paid on April 21, 2025 to shareholders of record as of the close of business on April 10, 2025.
By Retractable Technologies, Inc. · Via Business Wire · March 28, 2025
Equity Bancshares, Inc. Will Announce First Quarter 2025 Results on April 15, 2025
Equity Bancshares, Inc. (NYSE:EQBK), (“Equity”), the Wichita-based holding company of Equity Bank, will release its first quarter results on Tuesday, April 15, 2025, with a press release issued after market close.
By Equity Bancshares · Via Business Wire · March 28, 2025
FDA Approves Qfitlia™ (fitusiran), the First siRNA (RNAi Therapeutic) for the Treatment of Hemophilia A or B
Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today highlighted the significance of the U.S. Food and Drug Administration’s (FDA) approval of Qfitlia™ (fitusiran), the sixth Alnylam-discovered RNAi therapeutic approved in the U.S., and the first and only therapeutic to lower antithrombin (AT), a protein that inhibits blood clotting, with the goal of promoting thrombin generation to rebalance hemostasis and prevent bleeds. Qfitlia is indicated in the U.S. for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in adult and pediatric patients 12 years of age and older with hemophilia A or B, with or without factor VIII or IX inhibitors (neutralizing antibodies). Alnylam scientists discovered Qfitlia, published the first clinical data in the New England Journal of Medicine in 2017 showing reduced bleeding rates in hemophilia patients, and initiated the Phase 3 development program. In 2014, Sanofi obtained global rights to co-develop and co-commercialize Qfitlia under a license and collaboration agreement. The agreement was amended in 2018, with Sanofi obtaining global development and commercialization rights to Qfitlia, and Alnylam becoming eligible to receive tiered royalties of 15 to 30 percent on global net sales.
By Alnylam Pharmaceuticals, Inc. · Via Business Wire · March 28, 2025
KB Home Announces the Grand Opening of Its Newest Community in Corona, California
KB Home (NYSE: KBH), one of the largest and most trusted homebuilders in the U.S., today announced the grand opening of its newest community, Monteverdi, in the desirable Horsethief Canyon neighborhood of Corona, California. The new homes are designed for the way people live today, with popular interior features like modern kitchens overlooking large great rooms, bedroom suites with walk-in closets, and ample storage space. The one- and two-story homes at Monteverdi offer up to five bedrooms and three-and-a-half baths. Homeowners will appreciate the gorgeous mountain views as well as the proximity to local schools.
By KB Home · Via Business Wire · March 28, 2025
BankUnited, Inc. to Announce First Quarter Results
BankUnited, Inc. (NYSE: BKU) announced today that financial results for the quarter ended March 31, 2025 will be made public in a news release on Monday, April 28, 2025 prior to the market opening.
By BankUnited, Inc. · Via Business Wire · March 28, 2025
Aptiv to Release First Quarter 2025 Financial Results
Aptiv PLC (NYSE: APTV) will release its first quarter 2025 financial results on May 1, 2025 and will hold an investor call the same day at 8:00 a.m. ET. The call will be hosted by Aptiv's Chair and Chief Executive Officer, Kevin Clark, and Executive Vice President and Chief Financial Officer, Varun Laroyia.
By Aptiv PLC · Via Business Wire · March 28, 2025
Metropolitan Issues Statement on State’s Fourth Snow Survey of the Season
Metropolitan Water District General Manager Deven Upadhyay issues the following statement on the California Department of Water Resources’ fourth snow survey of the season:
Antithrombin Blood Test from Siemens Healthineers Now FDA Cleared as a Companion Diagnostic for Qfitlia, a Sanofi Hemophilia Therapy
Siemens Healthineers announced today its Innovance Antithrombin assay has achieved FDA clearance for a new claim allowing it to be used as a companion diagnostic test for people receiving treatment with Qfitlia™ (fitusiran), a Sanofi hemophilia therapy.1 Hemophilia is a lifelong genetic bleeding disorder that significantly affects the day-to-day lives of people living with the disease, creating potentially life-threatening risks from otherwise normal situations experienced by those without hemophilia. The body’s inability to clot blood effectively can prolong bleeding after injuries, result in excessive bruising and joint pain, and increase risks during surgery or other medical procedures.
By Siemens Healthineers · Via Business Wire · March 28, 2025
BNY Mellon Municipal Bond Closed-End Funds Declare Distributions
BNY Mellon Investment Adviser, Inc. announced today that BNY Mellon Municipal Income, Inc., BNY Mellon Strategic Municipal Bond Fund, Inc. and BNY Mellon Strategic Municipals, Inc. (each, a "Fund") have declared a monthly distribution for each Fund's common shares as summarized below. The distributions are payable April 30, 2025 to shareholders of record on April 14, 2025, with an ex-dividend date of April 14, 2025.
Pacific Coast Oil Trust Announces Monthly Net Profits Interest Calculations
PACIFIC COAST OIL TRUST (OTC–ROYTL) (the “Trust”), a royalty trust formed by Pacific Coast Energy Company LP (“PCEC”), announced today that there will be no cash distribution to the holders of its units of beneficial interest of record on March 28, 2025 based on the Trust’s calculation of net profits generated during January 2025 (the “Current Month”) as provided in the conveyance of net profits interests and overriding royalty interest (the “Conveyance”). As further described below under “Update on Estimated Asset Retirement Obligations,” based on information from PCEC, any monthly payments that PCEC may make to the Trust may not be sufficient to cover the Trust’s administrative expenses and outstanding debt to PCEC, and therefore the likelihood of distributions to the unitholders in the foreseeable future is extremely remote. As further described below under “Status of the Dissolution of the Trust”, because the annual cash proceeds received by the Trust from its net profits interests (the “Net Profits Interests”) and 7.5% overriding royalty interest (the “Royalty Interest”) totaled less than $2.0 million for each of 2020 and 2021, the amended and restated trust agreement governing the Trust (the “Trust Agreement”) provides that the Trust is to be dissolved and wound‑up. All financial and operational information in this press release has been provided to the Trustee by PCEC.
By Pacific Coast Oil Trust · Via Business Wire · March 28, 2025
Verde Clean Fuels, Inc. Reports Q4 and FY 2024 Results
Verde Clean Fuels, Inc. (“Verde” or “the Company”) (NASDAQ: VGAS) today reported results for the fourth quarter and full year 2024.
By Verde Clean Fuels, Inc. · Via Business Wire · March 28, 2025
bluebird bio Confirms Receipt of an Unsolicited Non-Binding Proposal from Ayrmid
bluebird bio, Inc. (NASDAQ: BLUE) (“bluebird”) today confirmed it has received an unsolicited non-binding written proposal (the “Ayrmid Proposal”) from Ayrmid Ltd (“Ayrmid”) to acquire bluebird for an upfront cash payment of $4.50 per share and a one-time contingent value right of $6.84 per share payable upon achievement of a net sales milestone.
By bluebird bio, Inc. · Via Business Wire · March 28, 2025
First Trust Advisors L.P. Announces Distribution for First Trust Enhanced Short Maturity ETF
First Trust Advisors L.P. ("FTA") announces the declaration of the Monthly distribution for First Trust Enhanced Short Maturity ETF, a series of First Trust Exchange-Traded Fund IV.
By First Trust Advisors L.P. · Via Business Wire · March 28, 2025
J.D. Power Ranks Banner Bank Highest in the Northwest for Retail Customer Satisfaction
The Banner Bank leadership team is pleased to announce the Bank ranked highest in the Northwest region for customer satisfaction in the just-released J.D. Power U.S. Retail Banking Satisfaction Study. This is the fifth time* in the past decade Banner Bank has earned this recognition.
By Banner Bank · Via Business Wire · March 28, 2025
Boxlight Reports Fourth Quarter and Full Year 2024 Financial Results
Boxlight Corporation (Nasdaq: BOXL) (“Boxlight” or the “Company”), a leading provider of interactive technology solutions, today announced the Company’s financial results for the fourth quarter and full year ended December 31, 2024.
By Boxlight Corporation · Via Business Wire · March 28, 2025
Vertex Announces Program Updates for Type 1 Diabetes Portfolio
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced several updates on the Company’s type 1 diabetes (T1D) portfolio.
Sixth Street Specialty Lending, Inc. Schedules Earnings Release and Conference Call to Discuss its First Quarter Ended March 31, 2025 Financial Results
Sixth Street Specialty Lending, Inc. (NYSE: TSLX) (“TSLX” or “the Company") announced today that it will release its financial results for the first quarter ended March 31, 2025 on Wednesday, April 30, 2025, after the market closes. TSLX invites all interested persons to its webcast / conference call on Thursday, May 1, 2025 at 8:30 a.m. Eastern Time to discuss its first quarter ended March 31, 2025 financial results.